ProPhase Labs (NASDAQ: PRPH) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $3.55 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.